Phagocytosis Functional Assay

• Use viable phagocytic cells appropriate to the biological question, such as primary human neutrophils, THP-1-derived macrophage-like cells, primary human macrophages, murine macrophages, HL-60-derived phagocytes, or tissue-derived microglia/macrophages, because these cell types have been used in published phagocytosis assays.

• Use particulate targets matched to the assay aim, including fluorescent Staphylococcus aureus, pHrodo-labeled Porphyromonas gingivalis, pHrodo-labeled Group B Streptococcus, pHrodo-labeled beads, yeast particles, bacterial particles, or pHrodo-labeled myelin.

• Use serum, purified antibody, complement-containing serum, or no-opsonin conditions only when the assay objective is to measure opsonophagocytosis or compare opsonin-dependent versus unopsonized uptake.

• Use pHrodo Red or Green labeling when the readout is intended to increase after phagosomal acidification, and use FITCor genetically fluorescent targets when total cell-associated target fluorescence is measured by flow cytometry.

• Ethidium bromide has been used to quench extracellular FITC-labeled bacteria and distinguish adherent from ingested bacteria in human neutrophil flow-cytometry assays.

• Cell-identification or viability markers may be included when needed for gating phagocytes or excluding debris and non-target events.

• Use a flow cytometer for quantitative single-cell measurement of phagocyte-associated fluorescence, and use fluorescence microscopy, confocal microscopy, or high-content imaging when intracellular localization or kinetic image-based readout is required.

• Use standard cell-culture equipment, refrigerated centrifugation, and fluorescence-compatible plates or tubes according to the selected cell type and target-preparation method.

• Prepare phagocytic cells under conditions matched to the cell model: primary neutrophils can be isolated from blood for short-term assays, HL-60 cells can be differentiated into phagocyte-like effector cells for opsonophagocytosis assays, THP-1 cells and primary macrophages can be used for pHrodo particle assays, and microglia/macrophages can be isolated from nervous tissue for myelin phagocytosis analysis.

• Prepare fluorescent particulate targets before the assay;
• Published examples include FITC-labeled or genetically fluorescent S. aureus, pHrodo-labeled P. gingivalis, pHrodo-labeled fixed Group B Streptococcus, pHrodo-labeled beads, pHrodo-labeled yeast or bacterial particles, and pHrodo Green STP Ester-labeled myelin.

• For opsonophagocytosis experiments, incubate targets with serum, antibody, complement-containing serum, or defined antibody/complement combinations before adding them to phagocytes, because published assays show that opsonization can strongly affect uptake and is required when measuring functional antibody activity.

• Include an unopsonized or no-serum condition when the aim is to measure baseline uptake or confirm opsonin dependence.

• Seed or suspend phagocytes in assay medium, add fluorescent targets at the selected target-to-cell ratio, and incubate under uptake-permissive conditions;
• Published neutrophil assays have used bacterial-to-cell ratios including 1:1, 1:10, and 1:100 over a 60-minute kinetic period, while a S. aureus neutrophil flow assay reported a 10:1 bacteria-to-cell ratio with 15-minute incubation for standard acquisition.

• For temperature controls, include an ice or 4°C condition when supported by the design, because low-temperature incubation has been used as a reduced-uptake control in phagocytosis assays.

• Stop uptake at the defined time point by cooling, washing, fixation, or immediate cytometric acquisition according to the cited assay format;
• Washing is used to remove excess fluorescent target, and fluorescence-quenching approaches such as ethidium bromide quenching of extracellular FITC-labeled bacteria can be used when the target dye and assay design support discrimination of extracellular adherent targets from internalized bacteria.

• When using pHrodo-labeled targets, acquire fluorescence in the appropriate channel because signal increases in acidic phagosomal compartments and supports detection of internalized particles.

• For flow cytometry, gate the phagocyte population by scatter and, when needed, by cell marker or nuclear/viability staining, exclude debris and free target particles, and quantify the percentage of fluorescent phagocytes and/or mean fluorescence intensity as measures of phagocytic participation and particle burden per cell.

• For imaging, acquire fluorescence images of phagocytes and targets, and use image analysis to quantify internalized target signal per cell or time-dependent uptake when a kinetic imaging system is used.

• Report phagocytosis as percentage of target-positive phagocytes, mean fluorescence intensity of the phagocyte population, a phagocytic score, or kinetic fluorescence over time, because these readouts have been used in flow-cytometry and imaging-based phagocytosis studies.

• Interpret pHrodo signal as uptake into acidic intracellular compartments rather than total target binding, while FITC or genetically fluorescent target signal may require quenching, microscopy confirmation, or other controls to distinguish internalized target from surface-associated target.

• Use negative controls that match the assay question, such as phagocytes without fluorescent target, targets without opsonin, low-temperature incubation, or actin-disruption conditions such as cytochalasin D when specifically testing active phagocytosis.

• Use positive or comparator controls such as serum-opsonized bacteria, antibody/complement-supported opsonophagocytosis conditions, or a reference donor serum when evaluating opsonic capacity.

• Analyze biological replicates across independent donors, animals, or cell preparations when comparing biological groups, and analyze technical replicates when the assay format is plate-based or when fluorescence variability is expected.

High fluorescence is detected but intracellular uptake is uncertain:

Possible Cause
Fluorescent targets may be attached to the cell surface rather than internalized.
Solution
Use pH-sensitive target labeling, extracellular fluorescence quenching for FITC-labeled targets, or microscopy confirmation to distinguish internalized particles from adherent extracellular particles.

Weak phagocytosis signal is observed in bacterial uptake assays:

Possible Cause
The target may be insufficiently opsonized, or the assay may intentionally lack antibody/complement support.
Solution
Include serum, antibody, complement-containing serum, or defined antibody/complement conditions when measuring opsonin-dependent uptake, and compare them with unopsonized controls.

Flow-cytometry plots contain many non-cell events:

Possible Cause
Free bacteria, target particles, or debris may overlap with acquisition events.
Solution
Gate phagocytes by scatter and cell-associated fluorescence or cell-identification staining, and exclude free particles before calculating target-positive phagocytes.

Uptake cannot be separated from passive binding:

Possible Cause
The assay lacks a reduced-uptake control.
Solution
Include low-temperature incubation or cytochalasin D-treated conditions when the experimental design requires confirmation of active phagocytosis.